Raymond James Financial Inc. Buys Shares of 35,900 Semler Scientific, Inc. (NASDAQ:SMLR)

Raymond James Financial Inc. acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 35,900 shares of the company's stock, valued at approximately $1,939,000. Raymond James Financial Inc. owned 0.39% of Semler Scientific at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Jones Financial Companies Lllp acquired a new stake in shares of Semler Scientific during the fourth quarter worth $34,000. Larson Financial Group LLC acquired a new stake in shares of Semler Scientific in the 4th quarter worth $38,000. IFP Advisors Inc purchased a new stake in shares of Semler Scientific in the fourth quarter valued at about $54,000. Global Retirement Partners LLC increased its stake in shares of Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after acquiring an additional 500 shares during the period. Finally, Legal & General Group Plc raised its holdings in Semler Scientific by 65.4% during the fourth quarter. Legal & General Group Plc now owns 2,056 shares of the company's stock worth $111,000 after purchasing an additional 813 shares in the last quarter. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Lake Street Capital boosted their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.

Semler Scientific Stock Performance

NASDAQ:SMLR traded down $2.58 during trading hours on Monday, hitting $33.58. The company's stock had a trading volume of 376,693 shares, compared to its average volume of 420,657. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $81.56. The business's 50-day moving average is $35.75 and its two-hundred day moving average is $46.49. The company has a market capitalization of $322.27 million, a PE ratio of 6.84 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The business had revenue of $12.41 million during the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.